Document is current
Any future updates will be listed below
-
Authors
Zhuo, You-Qiong
Huang, Qi-Ming
Gu, Hao-Cheng
Wang, Ling-Fang
Tula, Dilnuer
Wei, Xing-Yu
Zhang, Zhou-Hang
Deng, Ke-Yu
Xin, Hong-Bo
-
Funding
Funding for this research was provided by:
Jiangxi Provincial Department of Science and Technology, China (20252BAC240701)
National Key Research and Development Program of China (2022YFA1104300)
National Key Research and Development Program of China (2022YFA1104300)
National Natural Science Foundation of China (81970256)
National Natural Science Foundation of China (82470454)
- License Information
-
More Information
Article History
Received: 14 July 2025
Accepted: 11 December 2025
First Online: 17 December 2025
Declarations
:
: This research was performed in accordance with the ethical principles set forth in the Declaration of Helsinki (2013 revision), with written informed consent obtained from all participating patients for tissue donation. The animal experiments were performed in accordance with the principles outlined in the Basel Declaration. This study received dual institutional ethical approvals: human subject protocols were authorized by the Institutional Review Board of the First Affiliated Hospital of Nanchang University (Approval no. 2023CDYFYYLK08-015, “Aging and diabetic nephropathy’s influence on the biological characteristics and functions of human urine-derived stem cells”; August 11, 2023), while animal experimental procedures were ratified by the Animal Research Ethics Board of Nanchang University (Approval no. 20250508001, “The Potential and Molecular Mechanism of Human Urine-Derived Stem Cells in the Treatment of Psoriasis”; May 8, 2025) in strict compliance with the Guidelines for the Care and Use of Animals.
: Not applicable.
: The authors declare no competing interests.
